July 23, 2025

Engineered Extracellular Vesicles Enriched with miR-214 Enhance the Efficacy of Chemotherapy for Ovarian Cancer

View Full Paper

Ask AI

Bookmark

Authors

WWW. WangUniversity of Science and Technology of China AAAyesha B. AlveroWayne State University YQYi QinNingxia Medical University

Discussion

Member takes

Implication

Engineered extracellular vesicles improve chemosensitivity and reduce tumor growth in ovarian cancer, indicating potential for treatment enhancements.

Key Points

Engineered small extracellular vesicles enriched with miR-214 enhance chemosensitivity in ovarian cancer.
Combining miR-214-sEVs with carboplatin reduced tumor growth and improved survival in mouse models.
Clathrin-mediated endocytosis allowed OC cells to internalize m214-sEVs, increasing therapeutic miRNAs.
miR-214-sEVs show promise in overcoming chemoresistance and reducing risks of tumor recurrence in ovarian cancer.

Cite This Study

Wang et al. (2025) studied this question.

synapsesocial.com/papers/689a061be6551bb0af8cdb2a https://doi.org/10.1101/2025.07.18.665422

View Full Paper

Ask AI

Bookmark

Implication

Engineered extracellular vesicles improve chemosensitivity and reduce tumor growth in ovarian cancer, indicating potential for treatment enhancements.

Engineered Extracellular Vesicles Enriched with miR-214 Enhance the Efficacy of Chemotherapy for Ovarian Cancer

Discussion

Member takes

Implication

Key Points

Cite This Study

Engineered Extracellular Vesicles Enriched with miR-214 Enhance the Efficacy of Chemotherapy for Ovarian Cancer

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider